Oct 9, 2024, 16:44
ctDNA during perioperative ChT in resectable gastric/GEJ cancer, summarised by Erman Akkus
Erman Akkus shared a post on X:
“ctDNA during perioperative ChT in resectable gastric/GEJ cancer
ctDNA detection rates
56% at baseline
37% After 1cycle ChT
25% after preoperative chemotherapy 15% after resection
Detection of ctDNA after 1 cycle of ChT -> RFSOS
Detection of ctDNA after surgery -> RFSOS
Correlations with pathologic responses?
ctDNA after adjuvant ChT?”
Authors: Cecilie Riis Iden, et al.
Erman Akkus is a medical oncology fellow at the Ankara University, Faculty of Medicine. Previously, he was an Internal Medicine Resident at the Ankara University, Faculty of Medicine. He was also a Visiting Researcher at the University of Oslo. He completed his education from the Medical University of Vienna.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 22, 2024, 05:59
Dec 22, 2024, 05:31